Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway.

about

Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway.

Item

http://www.wikidata.org/entity/Q50191951

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Parthenolide facilitates apopt ...... g the STAT3 signaling pathway.

@en

Parthenolide facilitates apopt ...... g the STAT3 signaling pathway.

@nl

type

Item

label

Parthenolide facilitates apopt ...... g the STAT3 signaling pathway.

@en

Parthenolide facilitates apopt ...... g the STAT3 signaling pathway.

@nl

prefLabel

Parthenolide facilitates apopt ...... g the STAT3 signaling pathway.

@en

Parthenolide facilitates apopt ...... g the STAT3 signaling pathway.

@nl

P1476

Parthenolide facilitates apopt ...... g the STAT3 signaling pathway.

@en

P2093

Hang Lu

http://www.w3.org/2001/XMLSchema#string

Hua Li

http://www.w3.org/2001/XMLSchema#string

Meng Lv

http://www.w3.org/2001/XMLSchema#string

Qingsheng Wang

http://www.w3.org/2001/XMLSchema#string

Yuping Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.

CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.

The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells.

Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.

Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.

Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer.

Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach

Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance?

Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer.

Dimethylaminoparthenolide, a water soluble parthenolide, suppresses lung tumorigenesis through down-regulating the STAT3 signaling pathway.

P304

3572-3579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.7739

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29467878

http://www.w3.org/2001/XMLSchema#string

P932

5796286

http://www.w3.org/2001/XMLSchema#string